.

Clovis Oncology reported $32.14M in Sales Revenues for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 14583M 1045M
Acadia Pharmaceuticals ACAD:US $ 134.56M 19.1M
Acorda Therapeutics ACOR:US $ 31.05M 8.52M
Agenus AGEN:US $ 20.93M 5.01M
Agios Pharmaceuticals AGIO:US $ 5.58M 4.75M
Anika Therapeutics ANIK:US $ 39.66M 2.96M
Arrowhead Research ARWR:US $ 32.41M 119.39M
AstraZeneca AZN:LN 884686.86M 17406.7M
Astrazeneca AZN:US $ 10771M 619M
Clovis Oncology CLVS:US $ 32.14M 2.1M
Eli Lilly And LLY:US $ 6488M 1322M
Enanta Pharmaceuticals ENTA:US $ 19.48M 0.76M
Esperion Therapeutics ESPR:US $ 18.84M 5K
GlaxoSmithKline GSK:LN 692900M 26100M
Halozyme Therapeutics HALO:US $ 152.36M 35.09M
Heron Therapeutics HRTX:US $ 27.63M 4.17M
Insmed INSM:US $ 65.22M 12.11M
Intrexon XON:US $ 2.91M 29.11M
Ligand Pharmaceuticals LGND:US $ 83.64M 37.95M
Merk MRK:US $ 14593M 1308M
Mirati Therapeutics MRTX:US $ 5.36M 4.65M
Neurocrine Biosciences NBIX:US $ 378.2M 67.6M
Novartis NOVN:VX SF 13085M 271M
Pfizer PFE:US $ 27742M 2081M
Puma Biotechnology PBYI:US $ 59.52M 13.78M
Rigel Pharmaceuticals RIGL:US $ 29.82M 13.08M
Sangamo Biosciences SGMO:US $ 29.38M 1.15M
Seattle Genetics SGEN:US $ 497.5M 71.04M
Ultragenyx Pharmaceutical RARE:US $ 89.34M 9.41M
Veracyte VCYT:US $ 72.86M 5.08M
YTE INCY:US $ 911.4M 178.16M